Crystal financial tombstone celebrating the close by Global Infrastructure Partners, part of BlackRock, of its fifth fund. (25LNL067)
Crystal financial tombstone celebrating the close by Global Infrastructure Partners, part of BlackRock, of its fifth fund. (25LNL067)
Custom crystal commemorating FDA approval of Gomekli, a treatment for the rare tumor disease ncurofibromatosis 1 (NF1). (25AZH094)
Crystal financial tombstone, featuring a sandblasted map of the world, recognizing a licensing and commercialization agreement between X4 Pharmaceuticals and Norgine. The agreement centers onthe drug Mavorixafor, and encompasses Europe, New Zealand, and Australia. (25LNL023)
Crystal deal toy commemorating a follow-on stock offering by Oculis. The Swiss biopharmaceutical company provides treatment for eye conditions such as diabetic macula edema and acute optic neuritis. (25AKL187)
Lucite tombstone, featuring a half-sphere on a circular base, recognizing the acquisition of a majority stake in CM Biomass. The Copenhagen-based wood pellet trading company serves as an alternative energy provider to European utilities. (21LJW228)
Logo-themed deal toy, incorporating spheres with logos, marking the acquisition of medical advocacy service provider MAP Health. The acquirer was Louisville, Kentucky-based health management software company SentryHealth. (23AKL284)
Crystal deal toy marking the acquisition of a royalty interest in global sales of pegcetacoplan, marketed under the brand names Empaveli and Aspavell. The drugs were developed for treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. (22AKL517)
Crystal financial tombstone commemorating bonds issued by Rakuten. The bond sale will help the Tokyo-based company expand its mobile operations. (22AKL374)
Lucite deal toy marking the acquisition of German IT consultant akquinet. The acquisition also included two data centers. (22LJW090)
